Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great post! Well said
My whole point to this point is they only made the announcement of doing Covid Testing a little over a month ago and if our tests are coming from China they were put on hold for a few weeks and I believe with the Florida kits ABMC worked out a deal that they would sell them under the condition that the Florida Health Department check the tests and validate them which should take 2-3 days after the initial tests are done. Once they have been validated I believe this will go crazy with updates. ABMC knows these tests have been validated and they are familiar with the manufacture so they are willing to put their name on the line here. Things will liven up here soon
I sure do, but that’s not what they acquired those shares for? Those insiders own the shares for much more than .05 their averages are around .13 cents. John Moreney got paid $50,000 or shares and he took shares of about 450,000 each time so you do the math. These insiders don’t want even money! Patience is the name of the game here. My average is under water but everything o have is telling me ABMC has much bigger things going on than .13
Let’s not lose sight that insiders MP Biomedicals who’s owned Valiant Co Ltd which is publicly traded on the China exchange owns 19.1% of the shares (4,738,601) at an average of .13 cents and then you have have John Moreney with Landmark Pegasus who owns 7.6% of the shares (2,331,628) both are insiders and have owned shares for many years. Don’t think for a second they will let ABMC blunder this opportunity! All the DD is there just be patient penny playas
https://markets.businessinsider.com/stocks/insider-activity/abmc?p=1
I emailed David Jordan yesterday who did the news piece on the 44K kits https://www.baynews9.com/fl/tampa/about-us/2018/03/29/dave-jordan
And one thing that stuck out to me which I believe is going to be amazing for us is after the tests have been given in Florida those tests will be sent to the Florida Health Department for a 2nd opinion which should publicly validate the tests were distributing which should be a huge push forward. Here’s his email back to me
B:
Thanks for watching.
The tests are from a NY state company and they have been given federal clearance for emergency use. And those results have to be confirmed by the health department.
There are a lot of faulty tests that give crazy results.
Again, thanks for watching. Be well!
Sent from my iPhone
On Apr 29, 2020, at 10:12 PM,
Here’s my email to him!
Hello David I did Happen to see your story about the 44,000 antibody kits for first responders and I wanted to ask if the tests have been validated and also how the results have been? I’m seeing a lot of information out there on these tests so I was curious if they were a reputable test since it’s not FDA cleared I think. Please let me know your thoughts and I guess if the testing has begun yet. Thank you
Bxxxxx
Sent from my iPhone
She hasn’t, I think she took over in 2011 or 2012. This company does not put out a lot of PR’s they never have. I went through the filings. This is obviously a different ballgame than just them handing out drug tests though. It’s obviously a world event and needs attention form the company. The thing is I believe they were behind schedule for 14-18’days due to export issues. Testing is going to be around for awhile and especially in other countries so I believe we will have 2-3 decent spikes short term
Yes sir I posted this the other night
ABMC’s test (manufactured by Zhejiang Orient Gene Biotech Co Ltd) is approved in Australia as of April 1st. COVID-19 test kits included on the ARTG for legal supply in Australia https://www.tga.gov.au/covid-19-test-kits-included-artg-legal-supply-australia
Not saying I agree with you about the past, but it’s safe to say they have never had this opportunity that we’re all in now. Something tells me these holders won’t let this get away without a much larger profit!
https://markets.businessinsider.com/stocks/insider-activity/abmc?p=1
Orients/ABMC tests now cleared for export! #37 on the list under testing devices
http://en.cccmhpie.org.cn/Web/Content.aspx?queryStr=w7x08q7x15x15o3w8w1vS9z8w7x1X10x16x0X10x16o3w8w1u9v1u9v3v2v3
Bill gates in bed with ABMC testing provider it seems https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2018/11/OPP1197153
ABMC’s test with Healgen and Orient Gene both on this list for testing devices https://www.360dx.com/coronavirus-test-tracker-launched-covid-19-tests
ABMC’s test (manufactured by Zhejiang Orient Gene Biotech Co Ltd) is approved in Australia as of April 1st. COVID-19 test kits included on the ARTG for legal supply in Australia
https://www.tga.gov.au/covid-19-test-kits-included-artg-legal-supply-australia
ABMC tests come froI Orient Gene which they have been highly validated by several researchers and now hospitals
http://www.orientgene.com/asp-en/company/about.aspx
http://dailutb.com/wp-content/uploads/2020/03/Zhejiang-Orient-Gene-Biotech-COVID-19-OG.pdf
https://www.tandfonline.com/doi/full/10.1080/20008686.2020.1754538
Christushealth.org
http://www.christushealth.org/about/news/antibodies-test
CHRISTUS Health day’s game changer and they have validated it after weeks of testing
https://www.12newsnow.com/article/news/health/coronavirus/whats-the-difference-between-nasal-swabs-and-antibody-testing/502-ce227f59-80d6-4ac9-b0f1-1451430fb50f
ABMC/Healgens antibody test validated once again!
https://www.tandfonline.com/doi/full/10.1080/20008686.2020.1754538
There were no false IgM positive samples, indicating a very high specificity of the test.
The specificity and sensitivity for IgG detection of the rapid test evaluated here is well in line with those of a recently reported enzyme-linked immunosorbent assay (ELISA), which had a specificity and a sensitivity of 97.5% [20].
While this study showed a satisfactory performance of the rapid test, it is limited by being compared only to clinical cases and PCR-positivity, and as a next step, it is necessary to compare this assay to other serological tests. In contrast to Li et al. [11], we found less indications for using this test for clinical diagnosis. Nevertheless, it might contribute to detecting potential asymptomatic infections as well as getting a notion of the magnitude of the spread in different geographical areas, which might be a key to taking the appropriate decisions and policies forward. The high negative predictive value indicates that the rapid test will be useful for detecting past infections and possible immunity, which may be crucial for restoring social functions after lockdown.
Acknowledgments
This work was supported by the Swedish Research Council (VR, grant numbers 2016-02596, 2017-05807 and 2018-02569). The rapid tests that have enabled this study were donated to us by the Swedish company Noviral AB (organization number: 559175-7942).
CHRISTUS Health just validated Healgen antibody tests and said they have spent weeks testing the device and its accuracy. Call it a game changer and now offer it in all their hospitals!
https://www.12newsnow.com/article/news/health/coronavirus/whats-the-difference-between-nasal-swabs-and-antibody-testing/502-ce227f59-80d6-4ac9-b0f1-1451430fb50f
Same test as ABMC been validated, game changer
http://www.christushealth.org/about/news/antibodies-test
This could be where the kits come from and Bill Gates has a connection with them
If you read that box from Healgen it comes from Shanghai international holding Corp out of Germany
http://www.shholdingeu.com/eng/index.html
No it would be premature! They announced on 3/24 I believe they were marketing a covid device, since then only a short month we have verified sales in Ecuador, orders to the state Louisiana government and 44,000 test kits to Florida govt so I’d say not bad Ins month especially since they are still under FDA review and possibly could have been held up in China which is still undetermined! Not a bad first month I’d say
That’s the bigger story here! MP Biomedicals LLC has been acquiring shares of ABMC for several years and they now own 4,738,601- 18.2% ownership since this last filing back in 2016 and they still own the shares https://www.otcmarkets.com/filing/html?id=11233480&guid=fDNHUnLeS6t8s3h MP Biomedicals LLC is an internatiional Life Science company https://www.mpbio.com/ which they have worldwide locations in Singapore, Tokyo, Shanghai, Mumbai India,Korea, Australia. New Zealand, France,Germany,Moscow,Serbia, Poland, USA 2 locations, and Brazil, with thousands of employees. Vice President and CFO Thomas Stankovich who signed all the shares being acquired from ABMC https://www.linkedin.com/in/thomasstankovich/ MP Biomedicals LLC is also owned by Valiant CO, Ltd of china who is publicly traded in china and is a HUGE company with lots of subsidiaries who manufacture in ASIA. http://www.valiant-cn.com/ About Valiant Valiant Co., Ltd. is a scientific and technological international industrial group. With more than 30 years of development, we have gradually accumulated strong chemical synthesis technology & rapid industrialization advantages by insisting on developing more advanced new material processes and producing high-quality new material products. Currently, more than 60,000 kinds of Valiant’s advanced manufacturing materials are being used worldwide, and we are at the cutting-edge domains such as high-end display materials, zeolite series environmental friendly materials and life science sample preparation. Market performance 1. We are the largest producer in Asia and the world's largest supplier in the field of liquid crystal singles. 2. We are the world's largest and most technologically advanced manufacturer in the field of high-end zeolite series environmentally friendly materials. 3. We are the global market leader in the field of rapid preparation of samples for life sciences. 4. We are an important member of the world and the most capable manufacturer in China in the field of OLED materials, and also a leading enterprise in China's OLED independent innovation materials. All these connections worldwide
Bye felisha
America and the USA government don’t have a choice in where they buy. This is an eye opener even for the lowly democrats to see why we need America back producing products and medicines. You shouldn’t have sold you wouldn’t have to come back and bash after being a big pusher here
I can’t believe nobody is grasping that MP Biomedicals has over 19% of shares in ABMC. Do some research tonight on that company and their parent company in CHINA Valiant Co Ltd and there will be a whole new world opened to the possibilities of testing for ABMC
MP Biomedicals LLC has been acquiring shares of ABMC for several years and they now own 4,738,601- 18.2% ownership since this last filing back in 2016 and they still own the shares https://www.otcmarkets.com/filing/html?id=11233480&guid=fDNHUnLeS6t8s3h
MP Biomedicals LLC is an internatiional Life Science company https://www.mpbio.com/ which they have worldwide locations in Singapore, Tokyo, Shanghai, Mumbai India,Korea, Australia. New Zealand, France,Germany,Moscow,Serbia, Poland, USA 2 locations, and Brazil, with thousands of employees.
Vice President and CFO Thomas Stankovich who signed all the shares being acquired from ABMC https://www.linkedin.com/in/thomasstankovich/
MP Biomedicals LLC is also owned by Valiant CO, Ltd of china who is publicly traded in china and is a HUGE company with lots of subsidiaries who manufacture in ASIA.
http://www.valiant-cn.com/
About Valiant
Valiant Co., Ltd. is a scientific and technological international industrial group. With more than 30 years of development, we have gradually accumulated strong chemical synthesis technology & rapid industrialization advantages by insisting on developing more advanced new material processes and producing high-quality new material products.
Currently, more than 60,000 kinds of Valiant’s advanced manufacturing materials are being used worldwide, and we are at the cutting-edge domains such as high-end display materials, zeolite series environmental friendly materials and life science sample preparation.
Market performance
1. We are the largest producer in Asia and the world's largest supplier in the field of liquid crystal singles.
2. We are the world's largest and most technologically advanced manufacturer in the field of high-end zeolite series environmentally friendly materials.
3. We are the global market leader in the field of rapid preparation of samples for life sciences.
4. We are an important member of the world and the most capable manufacturer in China in the field of OLED materials, and also a leading enterprise in China's OLED independent innovation materials.
All these connections worldwide
I read the filings last night for about 4-5 hours all the way back until 2006 and John with Pegasus were paid for financial services for a minimum of 6 months and the company paid a retainer fee of $50,000 payable on usually shares of common stock right around 450,000 each time. They still own the shares and I see it only as a great thing they still have ownership and those shares. I also found something else much bigger which I’ll post in a few
We should be seeing a filing for DEF 14A within 2 days announcing a shareholder meeting in the middle of June
John Moreny taken from his bio, he knows how to buy shares!
Additionally, he served from 2010 to 2014 as the Chairman of Bedminster Financial Group Ltd., a licensed broker-dealer and member of FINRA, SIPIC and MSRB.
Here I’ll help you it’s him ABMC in his bio
JOHN J. MORONEY
FOUNDER AND PRESIDENT
Mr. Moroney is the Founder and President of Landmark Pegasus, Inc., and a seasoned business leader in both the Life Science and Healthcare industries, with extensive experience in corporate strategy, business development, finance and operational management.
Landmark was founded in 1983 and focused initially on development stage life science companies, with a special emphasis on generic drug companies. Among its early clients was Par Pharmaceutical (ENDO) , Sidmak Laboratories, Copley Pharmaceutical, Barr Laboratories, Zenith Pharmaceutical — now all part of TEVA.
Prior to founding Landmark, Mr. Moroney spent 10 years in commercial banking with Citibank, United Jersey Bank and Midlantic Banks, where he gained extensive experience in commercial lending and the use of the Economic Development Agency programs to fund emerging companies both in New Jersey and New York State.
Between 1985 and 1991 Landmark operated under an exclusive arrangement with Ladenburg Thalmann & Co., Inc., one of the oldest investment banks in New York, with Mr. Moroney serving as Managing Director of their Life Science group. During this period, Landmark served as investment banker to many noted Life Science companies, including the IPOs of Par Pharmaceutical, Alfin Fragrances, and Physicians Computer Network, Landmark also advised Columbia Laboratories on their IPO and their first product acquisition.
Landmark was also retained to restructure and finance Carrington Laboratories and MacroChem Laboratories. Mr. Moroney advised on Copley Pharmaceutical’s restructuring and subsequent private placement of equity and served as a director of the company until the sale of that interest to TA Associates. Landmark also introduced and advised F. Faulding & Co.Ltd., (Australia’s largest pharmaceutical company) on the acquisition of Solvay’s Purepac division.
In 1991, Ladenburg Thalmann underwent a change of ownership and management, and their exclusive arrangement with Landmark ended on amicable terms. While affiliated with Ladenburg, Mr. Moroney developed a unique service niche specializing in assisting foreign clients to become established in the US, and developing various strategies for U.S. market penetration. Landmark implemented a very successful strategy of cross border merger and acquisitions, licensing and joint ventures for their clients.
Through these assignments, Landmark has gained the trust and respect of our clients and they have experienced greater access to the capital markets which in turn has resulted in higher valuations and greater liquidity for them. During Landmark’s long history of servicing and advising clients in the healthcare arena, the Company has developed a vast network of both domestic and international industry relationships. Landmark’s clients have included Elan Pharmaceuticals, Fresenius, Ethypharm, Serono, Altana AG, Dynamit Nobel, and Drug Royalty Corp.
Starting in 1991, Landmark expanded their services to include the Nutrition industry, which today represents a large percentage of the company’s business. Clients have includes Nutrition21, Rexall Sundown, Balchem, Glanbia, Twin Labs (LBO) and a 25 year relationship with Pharmachem Laboratories, one of the largest branded ingredient manufacturer’s in the U.S. Medical Foods clients have included Medifast, Inc. (MED) and Pam Labs (Nestle).
Landmark continued their restructuring practice working with many companies like IGI Labs (Teligent – TLGT), Precision Optics, Inc (PEYE), American Bio Medica Corporation (ABMC), and Materials Processing Technology, Inc.
Mr. Moroney is also an experienced entrepreneur and investor, having active interests in pharmaceuticals, nutritionals, diagnostics and medical device companies. He was the co-founder of Flemington Pharmaceuticals, where he served for 10 years in various capacities including Chairman and CEO. He presided over the Company’s IPO and follow-on financings. He divested his holdings in 2003 with the completion of a financing to Paramount Capital. He was also the co-founder of Juvent Inc., a medical device company, Compliant Rx Solutions, Inc., a pharmaceutical services company, MD Diagnostics, and Dermworx Inc. Additionally, he served from 2010 to 2014 as the Chairman of Bedminster Financial Group Ltd., a licensed broker-dealer and member of FINRA, SIPIC and MSRB.
Mr. Moroney holds a B.S. and M.B.A. from Fordham University, and is a member of the Licensing Executives Society and the American Chemical Society.
Here I’ll help you, read ABMC
ABMC in his bio
JOHN J. MORONEY
FOUNDER AND PRESIDENT
Mr. Moroney is the Founder and President of Landmark Pegasus, Inc., and a seasoned business leader in both the Life Science and Healthcare industries, with extensive experience in corporate strategy, business development, finance and operational management.
Landmark was founded in 1983 and focused initially on development stage life science companies, with a special emphasis on generic drug companies. Among its early clients was Par Pharmaceutical (ENDO) , Sidmak Laboratories, Copley Pharmaceutical, Barr Laboratories, Zenith Pharmaceutical — now all part of TEVA.
Prior to founding Landmark, Mr. Moroney spent 10 years in commercial banking with Citibank, United Jersey Bank and Midlantic Banks, where he gained extensive experience in commercial lending and the use of the Economic Development Agency programs to fund emerging companies both in New Jersey and New York State.
Between 1985 and 1991 Landmark operated under an exclusive arrangement with Ladenburg Thalmann & Co., Inc., one of the oldest investment banks in New York, with Mr. Moroney serving as Managing Director of their Life Science group. During this period, Landmark served as investment banker to many noted Life Science companies, including the IPOs of Par Pharmaceutical, Alfin Fragrances, and Physicians Computer Network, Landmark also advised Columbia Laboratories on their IPO and their first product acquisition.
Landmark was also retained to restructure and finance Carrington Laboratories and MacroChem Laboratories. Mr. Moroney advised on Copley Pharmaceutical’s restructuring and subsequent private placement of equity and served as a director of the company until the sale of that interest to TA Associates. Landmark also introduced and advised F. Faulding & Co.Ltd., (Australia’s largest pharmaceutical company) on the acquisition of Solvay’s Purepac division.
In 1991, Ladenburg Thalmann underwent a change of ownership and management, and their exclusive arrangement with Landmark ended on amicable terms. While affiliated with Ladenburg, Mr. Moroney developed a unique service niche specializing in assisting foreign clients to become established in the US, and developing various strategies for U.S. market penetration. Landmark implemented a very successful strategy of cross border merger and acquisitions, licensing and joint ventures for their clients.
Through these assignments, Landmark has gained the trust and respect of our clients and they have experienced greater access to the capital markets which in turn has resulted in higher valuations and greater liquidity for them. During Landmark’s long history of servicing and advising clients in the healthcare arena, the Company has developed a vast network of both domestic and international industry relationships. Landmark’s clients have included Elan Pharmaceuticals, Fresenius, Ethypharm, Serono, Altana AG, Dynamit Nobel, and Drug Royalty Corp.
Starting in 1991, Landmark expanded their services to include the Nutrition industry, which today represents a large percentage of the company’s business. Clients have includes Nutrition21, Rexall Sundown, Balchem, Glanbia, Twin Labs (LBO) and a 25 year relationship with Pharmachem Laboratories, one of the largest branded ingredient manufacturer’s in the U.S. Medical Foods clients have included Medifast, Inc. (MED) and Pam Labs (Nestle).
Landmark continued their restructuring practice working with many companies like IGI Labs (Teligent – TLGT), Precision Optics, Inc (PEYE), American Bio Medica Corporation (ABMC), and Materials Processing Technology, Inc.
Mr. Moroney is also an experienced entrepreneur and investor, having active interests in pharmaceuticals, nutritionals, diagnostics and medical device companies. He was the co-founder of Flemington Pharmaceuticals, where he served for 10 years in various capacities including Chairman and CEO. He presided over the Company’s IPO and follow-on financings. He divested his holdings in 2003 with the completion of a financing to Paramount Capital. He was also the co-founder of Juvent Inc., a medical device company, Compliant Rx Solutions, Inc., a pharmaceutical services company, MD Diagnostics, and Dermworx Inc. Additionally, he served from 2010 to 2014 as the Chairman of Bedminster Financial Group Ltd., a licensed broker-dealer and member of FINRA, SIPIC and MSRB.
Mr. Moroney holds a B.S. and M.B.A. from Fordham University, and is a member of the Licensing Executives Society and the American Chemical Society.
$ABMC 7.6% Owner 13G John Moroney http://landmarkpegasus.com/ 2,481,608 shares owned https://www.sec.gov/Archives/edgar/data/896747/000110465920051690/tm2017810d1_sc13ga.htm
Quote:
Item 2. (a) Name of Person Filing John J. Moroney (b) Address of the Principal Office or, if none, residence 118 Pegasus Drive Jupiter, FL 33477 ... 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,481,608 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ¨ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.6% based on the outstanding shares reported on the issuer’s 10-Q filed with the SEC for the quarterly period ended September 30, 2019.
https://www.linkedin.com/in/john-moroney-8417692a [Suppressed Image] http://landmarkpegasus.com/leadership/
Quote:
JOHN J. MORONEY FOUNDER AND PRESIDENT Mr. Moroney is the Founder and President of Landmark Pegasus, Inc., and a seasoned business leader in both the Life Science and Healthcare industries, with extensive experience in corporate strategy, business development, finance and operational management.
Here is the test results for Healgens antibody tests! Same as ours https://www.medicaldisposables.us/v/vspfiles/assets/images/pdf/COVID-19%20IgG%20IgM%20Performance%20characteristic.pdf
100% and over 97% overall
Validated by 4 different sources
ABMC, 44,000 test kits on the news https://www.baynews9.com/fl/tampa/news/2020/04/27/rapid-testing-kits-coming-soon-for-hillsborough-first-responders
ABMC
Bam 44,000 test kits https://www.baynews9.com/fl/tampa/news/2020/04/27/rapid-testing-kits-coming-soon-for-hillsborough-first-responders
These are Healgens test kits
NETE news out and starting to go
Healgens/ABMC rapid test Results 1.6 Conclusion
According to the result, compares with result of RT-PCR, the diagnostic sensitivity of IgM from COVID-19 IgG/IgM Rapid Test (Whole blood/Serum/Plasma)is 87.9% (87/99), and diagnostic specificity is 100%(14/14)?When the patient is on the recovery, the diagnostic sensitivity of IgG is 97.2% (35/36).
https://www.medicaldisposables.us/v/vspfiles/assets/images/pdf/COVID-19%20IgG%20IgM%20Performance%20characteristic.pdf
Validated by 4 different accounts
1. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011; 81: 85-164.
2. Masters PS, Perlman S. Coronaviridae. In: Knipe DM, Howley PM, eds. Fields virology. 6th ed. Lippincott Williams & Wilkins, 2013: 825-58.
3. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24: 490-502.
4. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-192.
https://www.medicaldisposables.us/v/vspfiles/assets/images/pdf/Lateral%20Flow%20COVID-19%20IgG-IgM%20PI%20-Generic%2020200214.pdf
ABMC partner FDA submission FDA Submission Number: EUA200056
Here is the test results for Healgens antibody tests! Same as ours https://www.medicaldisposables.us/v/vspfiles/assets/images/pdf/COVID-19%20IgG%20IgM%20Performance%20characteristic.pdf
Damn they’re out of stock and selling for $450.00 for 25 tests so $18.00 per test. ABMC has a great thing going, they even have resellers working for them!